Literature DB >> 3947698

Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts.

T R Kosten, M J Kreek, J Ragunath, H D Kleber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3947698     DOI： 10.1016/0006-3223(86)90150-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  13 in total

Review 1.  A risk-benefit assessment of naltrexone in the treatment of alcohol dependence.

Authors:  B J Berg; H M Pettinati; J R Volpicelli
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

2.  Serum cortisol secretion during heroin abstinence is elevated only nocturnally.

Authors:  Su-xia Li; Jing Li; David H Epstein; Xiang Yang Zhang; Thomas R Kosten; Lin Lu
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

Review 3.  Maintenance medication for opiate addiction: the foundation of recovery.

Authors:  Gavin Bart
Journal:  J Addict Dis       Date:  2012

Review 4.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

5.  Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?

Authors:  Maria A Sullivan; Adam Bisaga; John J Mariani; Andrew Glass; Frances R Levin; Sandra D Comer; Edward V Nunes
Journal:  Drug Alcohol Depend       Date:  2013-07-01       Impact factor: 4.492

6.  Acute HPA axis response to naltrexone differs in female vs. male smokers.

Authors:  Daniel J O Roche; Emma Childs; Alyssa M Epstein; Andrea C King
Journal:  Psychoneuroendocrinology       Date:  2009-10-17       Impact factor: 4.905

7.  Suppression of hypothalamic-pituitary-adrenal axis by acute heroin challenge in rats during acute and chronic withdrawal from chronic heroin administration.

Authors:  Yan Zhou; Francesco Leri; Ann Ho; Mary Jeanne Kreek
Journal:  Neurochem Res       Date:  2013-06-16       Impact factor: 3.996

8.  Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment.

Authors:  Scott M Hyman; Helen Fox; Kwang-Ik A Hong; Cheryl Doebrick; Rajita Sinha
Journal:  Exp Clin Psychopharmacol       Date:  2007-04       Impact factor: 3.157

Review 9.  Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence.

Authors:  J P Gonzalez; R N Brogden
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 10.  Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.

Authors:  Yan Zhou; Dmitri Proudnikov; Vadim Yuferov; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2009-11-12       Impact factor: 3.252
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.